TotalMarketCap

Roivant Sciences

ROIVNasdaq United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$26.509 B

$36.70 -4.00%

Close of 6 Nov 2026

As of 6 Nov 2026, Roivant Sciences (ROIV) has a market capitalization of $26.5B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$8.26M

#3171 by revenue

Earnings

-$299.8M

Loss-making

Shares outstanding

722,323,015

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #19ZoetisZTS$33.9B
  2. #20Genmab A/SGMAB$33.0B
  3. #21Roivant SciencesROIV$26.5B
  4. #22United TherapeuticsUTHR$24.1B
  5. #23InsmedINSM$23.9B

What if Roivant Sciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$39,091.75

Per share 1,065× higher

Bitcoin $1.53T

$2,115.19

Per share 57.6× higher

Apple $5.02T

$6,943.96

Per share 189× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for Roivant Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.